Divi's Lab News

Intimation of Trading Window closure from July 01, 2024 till 48 hours after the declaration of unaudited financial results of the Company for the quarter ending June 30, 2024.

The market showcases strong performance in diverse segments, with small-cap, mid-cap, and micro-cap stocks leading the positive momentum. Sectors like metal, pharma, and PSU banks also demonstrate resilience, marking a significant uptick in trading values amid the current market scenario.

Within the Nifty pack, UltraTech Cement, HDFC Bank, Divi's Lab, Coal India, and SBI were the top gainers while HCL Tech, Asian Paints, and Titan faced selling pressure. Shares of new-age companies like Paytm, Zomato, and Policybazaar traded higher by around 2% each after Morgan Stanley's bullish note.

Intimation of completion of tenure of Mr. K.V. K. Seshavataram as Independent Director of the Company w.e.f. 22.06.2024.

Intimation of completion of tenure of Mr. K.V.K. Seshavataram as Independent Director of the Company on June 22, 2024.

As per enclsoed letter.

Trent and BEL are expected to enter Nifty in the September rebalancing of NSE indices, as per JM Financial estimates, which are based average free float market capitalisation.

Transcript of Q4FY24 earnings call held on May 25, 2024.

In Monday's trading session, stocks like BHEL, Zydus Life, NMDC, ABFRL, and Naukri witnessed a build-up of fresh short positions due to a decline in stock prices and an increase in open interest, signaling a short build-up.

Copies of Newspaper Publication regarding extracts of Audited Financial Results of the Company for the quarter and year ended March 31, 2024.

As per enclosed letter.

Submission of weblink of Audio recording of earnings conference call Q4FY2024 held on May 25, 2024.

Divi's Laboratories Q4 Results: Net profit stood at Rs 321 crore in the corresponding quarter of the last financial year. The consolidated revenue in Q4 FY24 jumped 18% YoY to Rs 2,303 crore from Rs 1,951 crore reported in Q4 FY23. For the full financial year FY24, the consolidated profit after tax was reported at Rs 1,600 crore, a considerable drop from Rs 1,824 crore reported in FY23.

As per enclosed letter.

As per enclosed letter.

As per enclosed letter.

As per enclosed letter.

Nilima Prasad Divi, daughter of Murali Divi, the founder of Divi's Laboratories, a prominent pharmaceutical company in India, has recently acquired two properties in Hyderabad, totaling Rs 80 crore. The first property, located in Jubilee Hills, spans 12,000 sq ft with a built-up area of 200 sq ft. The second property, also covering 12,000 sq ft, was acquired for a similar amount from Moturi Surya Kamal Prasad, according to the sale deed documents provided by Zapkey.

Annual Secretarial Compliance Report for the year end 31.03.2024

Another couple of points which traders should keep in mind when taking a trade by looking at the matrix of build-up of short positions on the basis of open interest. Also check whether there is any extraordinary build-up of long positions in any out-of-money put option, especially any far-of-the-money out option.

Schedule of earnings conference call for 4th quarter and year ended FY 2023-24 to be held on May 25, 2024 at 14:30 hrs (IST).

ITC, ONGC, IRFC, Ircon International, BHEL, BEL, Sun Pharma, Nykaa, Tata Investment Corporation, Hindalco, Ashok Leyland, and Divi's lab will be releasing their March quarter report cards this week.

Information about proposed capacity addition as per enclosed disclosure.

Format of Initial Disclosure to be made by an entity identified as a Large Corporate.

As per attachment.

Submission of compliance certificate under Regulation 7(3) of SEBI (LODR) Regulations, 2015.

As per attachment.

Newspaper Clippings - Intimation of notice given to shareholders in respect of transfer of equity shares to IEPF account

Submission of Scrutinizer''s Report on e-voting on resolutions stated in Postal Ballot Notice dated February 10, 2024.

Submisssion of Voting results on the resolutions proposed vide Postal Ballot Notice dated February 10, 2024 and Scrutinizer''s Report thereon.

Newspaper advertisement relating to Postal Ballot Notice

Submission of Postal Ballot Notice dated February 10, 2024.

Suven has been 50% owned by Advent since 2022 acquisition, with the remaining with public and institutional shareholders while Cohance is wholly owned by the PE group. Now post merger, Advent will own 66.7% in the combined entity and the public shareholders the rest.

We herewith enclose the Transcript of earnings conference call held on February 10, 2024.

The aggregate earnings of the companies in the MOFSL universe exceeded expectations and rose 29% year-on-year (YoY) versus an estimated 19%. Earnings for the Nifty-50 jumped 17% YoY versus an estimated 11%.

Copies of Newspaper publication

Oil and Natural Gas Corporation Ltd (ONGC) reported a 9.9% year-on-year (YoY) decline in consolidated net profit for the quarter ended December 2023 to Rs 10,356 crore.

Revenue from operations in the reporting period increased 9% year-on-year to Rs 1,855 crore, compared with Rs 1708 crore in the corresponding period of last year.

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we are enclosing herewith the schedule of earnings conference call for the quarter and nine months ended December 31, 2023 to be held on February 10, 2024 at 14:00 hrs (IST).

DIVI''s LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2024 ,inter alia, to consider and approve the standalone and consolidated unaudited financial results for the quarter and nine months ended December 31, 2023